United States: FDA's Full Stamp Of Vaccine Approval Delivers Progress, But Issues With Vaccine Passports And Policies Are Looming - Ogletree, Deakins, Nash, Smoak & Stewart

United States: FDA's Full Stamp Of Vaccine Approval Delivers Progress, But Issues With Vaccine Passports And Policies Are Looming - Ogletree, Deakins, Nash, Smoak & Stewart

Mondaq

Published

On August 23, 2021, the U.S. Food and Drug Administration (FDA) granted full approval to Pfizer's COVID-19 vaccine.

Full Article